Family History and Genetics |
|
|
Clinical Trial: Family-Based Prevention Program for Childhood Anxiety
This study is currently recruiting patients.
|
Purpose
The purpose of this study is to evaluate the effectiveness of a short-term family-based prevention program for preventing anxiety disorders in at-risk children.
| Condition | Treatment or Intervention |
|---|---|
| Anxiety Disorders | Behavior: Family-Based Anxiety Prevention Program |
MedlinePlus related topics: Anxiety
Study Type: Interventional
Study Design: Prevention, Randomized, Open Label, Placebo Control, Parallel Assignment, Efficacy Study
Official Title: Family-Based Prevention for Childhood Anxiety
Expected Total Enrollment: 40
Study start: September 2003; Expected completion: December 2005
Anxiety disorder is a serious condition that can negatively impact a person's overall functioning. This study will enroll mothers with anxiety disorders and their children to determine whether a brief family-based intervention will reduce childhood anxiety better than standard care.
Participants will be randomly assigned to either the family-based prevention program or to evaluation only for 8 weeks. Participants in the prevention program will have weekly sessions with a therapist and will learn skills to help reduce anxiety. Self- and parent-reports, diagnostic interviews, a computerized memory task, and a videotaped parent-child interaction task will be used to assess participants. Assessments will be conducted at study start and one week after study completion (Week 9). Follow-up visits will be conducted at 6 and 12 months after study completion.
Eligibility
Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Mothers with anxiety disorder and their 7- to 12-year-old children
Location and Contact Information
Elise Baldwin 410-955-1544 elise.baldwin@jhmi.edu
Maryland
Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205, United States; Recruiting
Elise S. Baldwin 410-955-1544 elise.baldwin@jhmi.edu
Golda S. Ginsburg, PhD, Principal Investigator
Rachel L. Grover, PhD, Sub-Investigator
More Information
Record last reviewed: March 2005
Last Updated: March 2, 2005
Record first received: March 5, 2004
ClinicalTrials.gov Identifier: NCT00078728
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


